Effects of COVID-19 Infection on Beta-cell Function in Euglycemic Patients

NACompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

June 30, 2020

Primary Completion Date

October 31, 2021

Study Completion Date

December 31, 2021

Conditions
COVID19BETA-CELL FUNCTION
Interventions
DIAGNOSTIC_TEST

Stimulation test with arginine infusion in order to verify the possible existence of damage to the beta cell function induced by COVID-19 infection

"All participants will be subjected to the collection of glycemic data through continuous professional retrospective monitoring of blood glucose for seven days, positioned on the day the test will be performed. During the entire recording period, parameters such as mean glucose, estimated glycosylated hemoglobin, peak glucose and nadir, blood sugar levels above the limit of 140 mg / dL, average glucose values at 60 and 120 minutes after meals, standard deviation and variability coefficient.~The evaluation of insulin secretion will be evaluated by performing the stimulus test with arginine infusion according to validated protocols."

Trial Locations (1)

20157

Sacco University Hospital, Milan

All Listed Sponsors
collaborator

Luigi Sacco University Hospital

OTHER

lead

University of Milan

OTHER

NCT04463849 - Effects of COVID-19 Infection on Beta-cell Function in Euglycemic Patients | Biotech Hunter | Biotech Hunter